Share
Journal Information
Issue
Vol. 18. Issue 4.Pages 537-654 (July - August 2019)
Editorial
Genome-based nutritional strategies to prevent chronic liver disease
Sonia Roman
Ann Hepatol. 2019;18:537-8
Open access
Opinions
Hepatitis E and chronic liver damage in apparently immunocompetent individuals: Now what?
Santiago Mirazo, Juan Arbiza
Ann Hepatol. 2019;18:539-40
Open access
Viewpoints
Hepatitis E in Latin America
Rosa Elena Sarmiento-Silva, Francisco Arenas-Huertero
Ann Hepatol. 2019;18:541-2
Open access
Concise reviews
Current concepts in acute liver failure
Maximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
Open access
Liver disease in pregnancy: Medical aspects and their implications for mother and child
Carmen Selene García-Romero, Carolina Guzman, Alicia Cervantes, Marco Cerbón
Ann Hepatol. 2019;18:553-62
Open access
Original articles
Non-alcoholic fatty liver disease and neurological defects
Rita Moretti, Paola Caruso, Silvia Gazzin
Ann Hepatol. 2019;18:563-70
Open access
First detection of hepatitis E virus genotype 3 as a common infectious agent in patients with chronic liver damage in Mexico
Oliver Viera-Segura, Mauricio Realpe-Quintero, Arturo Panduro, Sonia Roman, Alexis Jose-Abrego, Karina Gonzalez-Aldaco, Jorge L. Trujillo-Ochoa, Nora A. Fierro
Ann Hepatol. 2019;18:571-7
Open access
Low serum vitamin D is independently associated with unexplained elevated ALT only among non-obese men in the general population
Shira Zelber-Sagi, Reut Zur, Tamar Thurm, Alex Goldstein, Ofir Ben-Assuli, Gabriel Chodick, Oren Shibolet
Ann Hepatol. 2019;18:578-84
Open access
Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?
Filiz Akyüz, Bilger Çavuş, Binnur Pınarbaşı, Mürvet Bozacı, Bülent Baran, Umit Akyuz, Ahmet Uyanıkoglu, Kadir Demir, ... Sabahattin Kaymakoglu
Ann Hepatol. 2019;18:585-9
Open access
Establishment of competitive binding assay to detect and differentiate hepatitis E virus infection
Jiyue Wen, Weizhuo Lu, Jihong Meng
Ann Hepatol. 2019;18:590-4
Open access
Endoscopic retrograde cholangiopancreatography versus surgery for choledocholithiasis – A meta-analysis
Fernando C. Schacher, Sofia M. Giongo, Fernanda J.P. Teixeira, Ângelo Z. Mattos
Ann Hepatol. 2019;18:595-600
Open access
Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients
Alisha Ahmed, Christopher Schriever, Nicholas Britt, Jenna Yager, Ronish Amin, Liam McGuey, Nimish Patel
Ann Hepatol. 2019;18:601-6
Open access
Prognostic value of hepatic encephalopathy for survival of patients with liver failure: A systematic review and meta-analysis
Hanqing Yu, Yu Chen, Ping Jiang
Ann Hepatol. 2019;18:607-12
Open access
Niemann-Pick disease A or B in four pediatric patients and SMPD1 mutation carrier frequency in the Mexican population
Magdalena Cerón-Rodríguez, Edgar Ricardo Vázquez-Martínez, Constanza García-Delgado, Alberto Ortega-Vázquez, Pedro Valencia-Mayoral, Lyuva Ramírez-Devars, Christian Arias-Villegas, Irma Eloísa Monroy-Muñoz, ... Verónica Fabiola Morán-Barroso
Ann Hepatol. 2019;18:613-9
Open access
Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats
Marcela M. De Luna-Saldivar, Iván A. Marino-Martinez, Moisés A. Franco-Molina, Lydia G. Rivera-Morales, Gabriela Alarcón-Galván, Paula Cordero-Pérez, Augusto Rojas-Martínez, Cristina Rodríguez-Padilla, Linda E. Muñoz-Espinosa
Ann Hepatol. 2019;18:620-6
Open access
The relationship between coagulation disorders and the risk of bleeding in cirrhotic patients
Asma Labidi, Héla Baccouche, Monia Fekih, Sonia Mahjoub, Nadia BenMustapha, Meriem Serghini, Neila BenRomdhane, Jalel Boubaker
Ann Hepatol. 2019;18:627-32
Open access
Folic acid ameliorates homocysteine-induced angiogenesis and portosystemic collaterals in cirrhotic rats
Hsin-Ling Ho, Ming-Hung Tsai, Yu-Hsin Hsieh, Teh-Ia Huo, Ching-Chih Chang, Fa-Yauh Lee, Hui-Chun Huang, Ming-Chih Hou, Shou-Dong Lee
Ann Hepatol. 2019;18:633-9
Open access
Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients
Seyed Y. Hosseini, Neda Sanaei, Mohamad-Reza Fattahi, Seyed A. Malek-Hosseini, Jamal Sarvari
Ann Hepatol. 2019;18:640-5
Open access
Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiency
Alejandra Consuelo-Sánchez, Rodrigo Vázquez-Frias, Alejandra Reyes-De La Rosa, Carlos P. Acosta-Rodríguez-Bueno, María P. Ortal-Vite, Jorge J. Cebolla
Ann Hepatol. 2019;18:646-50
Open access
Case report
Occult central pontine myelinolysis post liver transplant: A consequence of pre-transplant hyponatremia
Julie Zhu, Fatema Al-Alkim, Trana Hussaini, Alexandra Vertinsky, Danielle Byrne, Siegfried R. Erb, A. Jon Stoessl, Eric M. Yoshida
Ann Hepatol. 2019;18:651-4
Open access
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
